BOSTON, MA / ACCESSWIRE / September 21, 2022 / Block & Leviton announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (NASDAQ:FLGT) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/flgt.
What is this all about?
On August 4, 2022, after the market closed, Fulgent Genetics, Inc. released Q2 2022 financial results. Contained in the earnings release, Fulgent disclosed that the company had received a Civil Investigative Demand from the U.S. Department of Justice, investigating 'allegations of medically unnecessary laboratory testing, improper billing for laboratory testing, and remuneration received or provided in violation of the Anti-Kickback Statute and the Stark Law.'
Shares of Fulgent Genetics, Inc. fell as much as 7.7% in intraday trading on August 5, 2022, closing down 5.7% from the prior day's close.
Who is eligible?
Anyone who purchased Fulgent Genetics, Inc. stock between March 22, 2019 and August 4, 2022 is eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What should you do next?
The deadline to seek appointment as lead plaintiff is November 21, 2022. A class has not yet been certified, and until a certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Why should you contact Block & Leviton?
Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email email@example.com with any questions.
This notice may constitute attorney advertising.
SOURCE: Block & Leviton LLP
View source version on accesswire.com: